MiNK Therapeutics Inc. (INKT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MiNK Therapeutics Inc.

    NASDAQ: INKT · Real-Time Price · USD
    15.02
    -0.44 (-2.85%)
    At close: Oct 03, 2025, 3:59 PM
    14.50
    -3.43%
    After-hours: Oct 03, 2025, 07:06 PM EDT

    MiNK Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 4.58M 3.37M 19.64M 38.89M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a n/a
    Receivables
    		 n/a n/a n/a 23K
    Inventory
    		 n/a n/a n/a 1.76K
    Other Current Assets
    		 164.24K 177.96K 470.3K 719.56K
    Total Current Assets
    		 4.99M 3.6M 20.4M 39.63M
    Property-Plant & Equipment
    		 732.93K 953.98K 1.07M 606.6K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 732.93K 953.98K 1.07M 606.6K
    Total Assets
    		 5.72M 4.55M 21.47M 40.24M
    Account Payables
    		 2.73M 3.91M 5.82M 3M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 3.51M 5.66M 5.21M 12.89M
    Total Current Liabilities
    		 6.96M 11.4M 12.68M 16.47M
    Long-Term Debt
    		 4.92M n/a n/a n/a
    Other Long-Term Liabilities
    		 13.42M 11.21M 9.19M n/a
    Total Long-Term Liabilities
    		 18.35M 11.21M 9.19M 3M
    Total Liabilities
    		 25.31M 22.61M 21.87M 16.47M
    Total Debt
    		 4.92M n/a n/a n/a
    Book Value
    		 -19.59M -18.06M -401.3K 23.78M
    Book Value Per Share
    		 -5.23 -5.25 -0.12 7.10
    Common Stock
    		 40.00 346.00 339.00 335.00
    Retained Earnings
    		 -144.18M -133.4M -110.94M -82.95M
    Comprehensive Income
    		 -631.58K -430.95K -292.47K -625.27K
    Shareholders Equity
    		 -19.59M -18.06M -401.3K 23.78M
    Total Investments
    		 4.57B n/a n/a n/a

    Add to Watchlist